3550 John Hopkins Court
United States - Map
Verenium Corporation, an industrial biotechnology company, engages in the development and commercialization of enzymes for industrial processes in North America, Europe, South America, and Asia. The company manufactures and markets its proprietary enzyme products in the fields of animal health and nutrition, grain processing, oilfield services, and other industrial processes, such as pulp and paper, and textiles. Its animal health and nutrition product is Phyzyme XP phytase, an enzyme added to poultry and swine feed that promotes growth by enhancing the nutrition that animals extract from feed grains. The companys grain processing products comprise Fuelzyme alpha-amylase, an enzyme for starch liquefaction in the production of fuel ethanol and other industrial-use alcohols; DELTAZYM GA L-E5, a high-activity glucoamylase for the conversion of starch to sugars in fuel ethanol production; and Xylathin xylanase, an enzyme that enhances the efficiency of fuel ethanol production from cereal grains. Its oilfield services products include Pyrolase cellulase and Pyrolase HT cellulase, which are enzymes that break carbohydrates in the fluids used in oil and gas well operations; and Eradicake alpha-amylase enzyme, which breaks down starch. The companys other industrial processes products comprise Cottonase pectate lyase, a textile processing enzyme for cotton; and Luminase PB-100 xylanase, which enhances the reactivity of pulp fiber to bleaching chemicals. It also has enzyme product candidates in various stages of development for animal health and nutrition, grain and starch processing, and oilfield services markets. In addition, the company provides contract manufacturing services. Verenium Corporation has a strategic collaboration with Novus International, Inc. The company was formerly known as Diversa Corporation and changed its name to Verenium Corporation in June 2007. Verenium Corporation was founded in 1992 and is headquartered in San Diego, California.
|Mr. James E. Levine ,
Chief Exec. Officer, Pres and Director
|Mr. Jeffrey G. Black ,
Chief Financial Officer, Principal Accounting Officer and Sr. VP
|Ms. Janet S. Roemer ,
Chief Operating Officer, Exec. VP, Pres of Enzymes Bus. and Chief Operating Officer of Enzymes Bus.
|Mr. Alexander A. Fitzpatrick ,
Sr. VP, Gen. Counsel and Sec.
|Ms. Kelly Lindenboom ,
VP of Corp. Communications
|Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|